Viral Mandviwala - Zota Health Chief Officer
| ZOTA Stock | 1,430 54.80 3.69% |
Executive
Viral Mandviwala is Chief Officer of Zota Health Care
| Age | 49 |
| Address | Zota House, Surat, India, 394210 |
| Phone | 91 26 1233 1601 |
| Web | https://www.zotahealthcare.com |
Zota Health Management Efficiency
The company has return on total asset (ROA) of (0.0405) % which means that it has lost $0.0405 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3838) %, meaning that it generated substantial loss on money invested by shareholders. Zota Health's management efficiency ratios could be used to measure how well Zota Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Zota Health's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 2.7 B in 2025, whereas Intangible Assets are likely to drop slightly above 38.3 M in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Rajiv Puri | Fortis Healthcare Limited | 52 | |
| Biju Menon | Star Health and | N/A | |
| Sankaranarayanan Krishnan | Apollo Hospitals Enterprise | 56 | |
| Krishnakumar | Apollo Hospitals Enterprise | 61 | |
| Radha Vijayaraghavan | Star Health and | N/A | |
| Bhagwat Deora | JB Chemicals Pharmaceuticals | 42 | |
| Sanjay Sinha | Fortis Healthcare Limited | N/A | |
| Mukesh Sharma | Star Health and | N/A | |
| Sanjay Baweja | Fortis Healthcare Limited | N/A | |
| Himanshu Ranvah | JB Chemicals Pharmaceuticals | 39 | |
| Martin Ashcroft | Tata Chemicals Limited | N/A | |
| Himanshu Walia | Star Health and | 44 | |
| Amin Suresh | JB Chemicals Pharmaceuticals | 56 | |
| Suresh Bhise | JB Chemicals Pharmaceuticals | 59 | |
| Kannaiyapillai Harikrishnan | Star Health and | 69 | |
| Aneesh Srivastava | Star Health and | 56 | |
| Zeal Rupani | Procter Gamble Health | N/A | |
| Chittibabu | Star Health and | N/A | |
| Bhasker Sivalanka | Tata Chemicals Limited | 67 | |
| Mohanmenon Menon | Lotus Eye Hospital | N/A | |
| Subodh Srivastav | Tata Chemicals Limited | 59 | |
Management Performance
| Return On Equity | -0.38 | ||||
| Return On Asset | -0.0405 |
Zota Health Care Leadership Team
Elected by the shareholders, the Zota Health's board of directors comprises two types of representatives: Zota Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zota. The board's role is to monitor Zota Health's management team and ensure that shareholders' interests are well served. Zota Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zota Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Moxesh Zota, Executive Director | ||
| Viren Zota, Executive Director | ||
| Pulaila Sreekanth, Associate Resources | ||
| Ruben Parma, Manager HR | ||
| Sujit Paul, CEO Personnel | ||
| Manukant Zota, WholeTime Director | ||
| Himanshu Zota, WholeTime Director | ||
| Ashvin CS, Compliance Secretary | ||
| Niralkumar Zota, Senior Manager | ||
| Nitin khanna, Business Exports | ||
| Viral Mandviwala, Chief Officer | ||
| Ashvin Variya, Compliance Secretary | ||
| Laxmi Sharma, Executive Director | ||
| Kamlesh Zota, WholeTime Director |
Zota Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zota Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.38 | ||||
| Return On Asset | -0.0405 | ||||
| Profit Margin | (0.17) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 45.73 B | ||||
| Shares Outstanding | 30.33 M | ||||
| Shares Owned By Institutions | 0.05 % | ||||
| Price To Book | 19.83 X | ||||
| Price To Sales | 12.94 X | ||||
| Revenue | 2.93 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Zota Stock Analysis
When running Zota Health's price analysis, check to measure Zota Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zota Health is operating at the current time. Most of Zota Health's value examination focuses on studying past and present price action to predict the probability of Zota Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zota Health's price. Additionally, you may evaluate how the addition of Zota Health to your portfolios can decrease your overall portfolio volatility.